News

Scientists form new Seattle biotech, backed by $12M. Fate Therapeutics

A group of scientists who specialize in stem cell biology have formed a new biotech company backed by $12 million in original venture capital.

Fate Therapeutics will be based in Seattle and consists of leading scientists including Randall Moon of the University of Washington, who’s director of the Institute for Stem Cell and Regenerative Medicine. Other scientists come from Stanford University, Harvard University and Scripps Research Institute.

Full Story: http://www.bizjournals.com/seattle/stories/2007/11/26/daily23.html?ana=from_rss

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.